vanA -mediated high level glycopeptide resistance in MRSA
- 1 February 2003
- journal article
- reflection and-reaction
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 3 (2) , 67-68
- https://doi.org/10.1016/s1473-3099(03)00510-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Glycopeptide-resistant Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 2002
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfections in France: Emergence of a Single Clone That Produces Panton‐Valentine LeukocidinClinical Infectious Diseases, 2002
- Vancomycin Resistance in StaphylococciClinical Microbiology Reviews, 2002
- Vancomycin-resistant Staphylococcus aureus : a new model of antibiotic resistanceThe Lancet Infectious Diseases, 2001
- Low Dosage and Long Treatment Duration of β-LactamJAMA, 1998
- Glycopeptide resistance in enterococciTrends in Microbiology, 1996
- Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalisNCTC 12201 toStaphylococcus aureusFEMS Microbiology Letters, 1992
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988